|
Study Of Depression In Adults Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on Study Of Depression In Adults conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Study Of Depression In Adults Clinical research trials and Study Of Depression In Adults medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like Study Of Depression In Adults. Study Of Depression In Adults Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a Study Of Depression In Adults clinical trial. Participants frequently obtain the most expert healthcare available for their Study Of Depression In Adults condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Study Of Depression In Adults Study Of Depression In Adults
Study Of Depression In Adults
For Condition: Major Depressive Disorder
Status: No longer recruiting
Sponsor(s): Sponsor Name Pending ,
Synopsis: A Placebo Controlled Study Evaluating Efficacy, Safety and Tolerability of Medication in Patients with Major Depressive Disorder (MDD)
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/64 Years
Genders: Both
Protocol Entry Criteria: Inclusion - Diagnosis of Major Depressive Disorder (MDD) - Duration of current depressive episode 12 weeks - 24 months - Patients can read and write at a level sufficient to provide a signed consent - If female, patients must be practicing an acceptable method of birth control Exclusion Criteria - Patients have other psychiatric disorders that would affect patient's response to treatment - Patients have not responded to two or more adequate courses of antidepressant therapy - Patients cannot be currently abusing illicit drugs or alcohol - Patients are not currently receiving psychotherapy - Patients have received electroconvulsive therapy within 6 months prior to screening - Patients are pregnant or lactating
Total Enrollment:
Location and Contact Information:
Study Site
New York City, New York, 10021
United States
Study Site
Chula Vista, California, 91910
United States
Study Site
Irvine, California, 92618
United States
Study Site
Lake Jackson, Texas, 77566
United States
Study Site
Salem, Oregon, 97301
United States
Study Site
Florence, Kentucky, 71101
United States
Study Site
Austin, Texas, 78756
United States
Study Site
Chapel Hill, North Carolina, 27514
United States
Study Site
Raleigh, North Carolina, 27609
United States
Study Site
Scottsdale, Arizona, 85251
United States
Study Site
New York City, New York, 10016
United States
Study Site
Salt Lake City, Utah, 841047
United States
Study Site
Peoria, Arizona, 85381
United States
Study Site
Stanford, California, 94305
United States
Study Site
Galveston, Texas, 77555
United States
Study Site
Brockton, Massachusetts, 02301
United States
Study Site
Garden Grove, California, 92845
United States
Study Site
Winter Park, Florida, 32789
United States
Study Site
Terre Haute, Indiana, 91910
United States
Study Site
Lyndhurst, Ohio, 44124
United States
Study Site
Miami, Florida, 33173
United States
Study Site
Springfield, Illinois, 62791
United States
Study Site
Philadelphia, Pennsylvania, 19106
United States
Additional Information:
Study ID Numbers: OHB20002;
Study Start Date:
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00057213
Other Major Depressive Disorder Studies:
1. Treatment of Patients with Major Depressive Disorder with an Investigational Compound
2. Treatment of Depression in Nursing Homes
3. A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects with Major Depressive Disorder
4. Efficacy And Safety Of Three Fixed Doses Of DVS-233 SR In Adult Outpatients With Major Depressive Disorder
5. DVS-233 SR For Prevention Of Depressive Relapse In Adult Outpatients With Major Depressive Disorder
Related Studies:
Other Major Depressive Disorder Clinical Trials
Other Pennsylvania Clinical Trials
Other Philadelphia Clinical Trials
Study Of Depression In Adults
|
|
|
|
|
|
|
|